Gut microbiota, host health, and polysaccharides

Biotechnology Advances

Volumn 31, Issue 2, 2013, Pages 318-337

  Xu, Xiaofei ^a,b   Xu, Pingping ^a   Ma, Chungwah ^b   Tang, Jian ^b   Zhang, Xuewu ^a  

^a SOUTH CHINA UNIVERSITY OF TECHNOLOGY   (China)

^b Infinitus (China) Company Ltd   (China)

Author keywords

Diseases; Host health; Intestinal microbiota; Microbiome; Polysaccharides

Indexed keywords

DISEASE DEVELOPMENT; DRUG METABOLISMS; GUT MICROBIOTA; HOST PHYSIOLOGY; MICROBIOME; MICROBIOTAS; SPATIAL PATTERNING; TEMPORAL DYNAMICS;

DISEASES; IMMUNE SYSTEM; NUTRITION; PHYSIOLOGY; POLYSACCHARIDES;

HEALTH;

PATTERN RECOGNITION RECEPTOR; POLYSACCHARIDE;

BIOTECHNOLOGY; DIET; DIGESTIVE SYSTEM; DISEASE INCIDENCE; DRUG; ENVIRONMENTAL FACTOR; HOMEOSTASIS; IMMUNE SYSTEM; METABOLISM; MICROBIOLOGY; POLYSACCHARIDE; SPATIOTEMPORAL ANALYSIS;

AGING; ANIMAL; CYTOLOGY; DIET; ENDOPLASMIC RETICULUM; ENTERITIS; EPITHELIUM CELL; GASTROINTESTINAL TRACT; HOMEOSTASIS; HUMAN; IMMUNOLOGY; METABOLIC SYNDROME X; METABOLISM; METAGENOME; MICROBIOLOGY; PHYSIOLOGY; REVIEW;

AGING; ANIMALS; DIET; ENDOPLASMIC RETICULUM; EPITHELIAL CELLS; GASTROINTESTINAL TRACT; HOMEOSTASIS; HUMANS; INFLAMMATORY BOWEL DISEASES; METABOLIC SYNDROME X; METAGENOME; POLYSACCHARIDES; RECEPTORS, PATTERN RECOGNITION;

EID: 84873732539     PISSN: 07349750     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.biotechadv.2012.12.009     Document Type: Review

References (307)

1. Abell G.C., Christophersen C.T., McOrist A.L., Clarke J.M. Dietary resistant and butyrylated starches have different effects on the faecal bacterial flora of azoxymethane-treated rats. Br J Nutr 2011, 105(10):1480-1485.
2. Abreu M.T. Toll-like receptor signalling in the intestinal epithelium: how bacterial recognition shapes intestinal function. Nat Rev Immunol 2010, 10:131-144.
3. Ahern P.P., Schiering C., Buonocore S., McGeachy M.J., Cua D.J., Maloy K.J., et al. IL-23 drives intestinal inflammation through direct activity on T cells. Immunity 2010, 33:279-288.
4. Allen R.H., Stabler S.P. Identification and quantitation of cobalamin and cobalamin analogues in human feces. Am J Clin Nutr 2008, 87:1324-1335.
5. Allen I.C., TeKippe E.M., Woodford R.T., Uronis J.M., Holl E.K., Rogers A.B., et al. The NLRP3 inflammasome functions as a negative regulator of tumorigenesis during colitis-associated cancer. J Exp Med 2010, 207:1045-1056.
6. Antunes L.C., Finlay B.B. A comparative analysis of the effect of antibiotic treatment and enteric infection on intestinal homeostasis. Gut Microbes 2011, 2:105-108.
7. Antunes L.C., Han J., Ferreira R.B., Lolic P., Borchers C.H., Finlay B.B. Effect of antibiotic treatment on the intestinal metabolome. Antimicrob Agents Chemother 2011, 55:1494-1503.
8. Armougom F., Henry M., Vialettes B., Raccah D., Raoult D. Monitoring Bacterial Community of Human Gut Microbiota Reveals an Increase in Lactobacillus in Obese Patients and Methanogens in Anorexic Patients. PLoS One 2009, 4(9):e7125.
9. Artis D. Epithelial-cell recognition of commensal bacteria and maintenance of immune homeostasis in the gut. Nat Rev Immunol 2008, 8:411-420.
10. Arumugam M., Raes J., Pelletier E., Le Paslier D., Yamada T., Mende D.R., et al. Enterotypes of the human gut microbiome. Nature 2011, 473:174-180.
11. Asquith M., Powrie F. An innately dangerous balancing act: intestinal homeostasis, inflammation, and colitis-associated cancer. J Exp Med 2010, 207:1573-1577.
12. Atarashi K., Tanoue T., Shima T., Imaoka A., Kuwahara T., Momose Y., et al. Induction of colonic regulatory T cells byindigenous Clostridium species. Science 2011, 331:337-341.
13. Atarashi K., Umesaki Y., Honda K. Microbiotal influence on T cell subset development. Semin Immunol 2011, 23:146-153.
14. Bäckhed F., Ding H., Wang T., Hooper L.V., Koh G.Y., Nagy A., et al. The gut microbiota as an environmental factor that regulates fat storage. Proc Natl Acad Sci U S A 2004, 101:15718-15723.
15. Bäckhed F., Ley R.E., Sonnenburg J.L., Peterson D.A., Gordon J.I. Host-bacterial mutualism in the human intestine. Science 2005, 307:1915-1920.
16. Ballal S.A., Gallini C.A., Segata N., Huttenhower C., Garrett W.S. Host and gut microbiota symbiotic factors: lessons from inflammatory bowel disease and successful symbionts. Cell Microbiol 2011, 13:508-517.
17. Baran J., Allendorf D.J., Hong F., Ross G.D. Oral β-glucan adjuvant therapy converts nonprotective Th2 response to protective Th1 cell-mediated immune response in mammary tumor-bearing mice. Folia Histochem Cytobiol 2007, 45:107-114.
18. Barnes M.J., Powrie F. The gut's Clostridium cocktail. Science 2011, 331:289-290.
19. Bauer H., Horowitz R.E., Levenson S.M., Popper H. The response of the lymphatic tissue to the microbial flora. Studies on germfree mice. Am J Pathol 1963, 42:471-483.
20. Benjdia A., Martens E.C., Gordon J.I., Berteau O. Sulfatases and a radical S-adenosyl-L-methionine (AdoMet) enzyme are key for mucosal foraging and fitness of the prominent human gut symbiont, Bacteroides thetaiotaomicron. J Biol Chem 2011, 286:25973-25982.
21. Benson A.K., Kelly S.A., Legge R., Ma F.R., Low S.J., Kim J., et al. Individuality in gut microbiota composition is a complex polygenic trait shaped by multiple environmental and host genetic factors. Prod Natl Acad Sci USA 2010, 107:18933-18938.
22. Biagi E., Nylund L., Candela M., Ostan R., Bucci L., Pini E., et al. Through ageing, and beyond: gut microbiota and inflammatory status in seniors and centenarians. PLoS One 2010, 5(5):e10667.
23. Biswas A., Wilmanski J., Forsman H., Hrncir T., Hao L., Tlaskalova-Hogenova H., et al. Negative regulation of Toll-like receptor signaling plays an essential role in homeostasis of the intestine. Eur J Immunol 2011, 41(1):182-194.
24. Bjursell M.K., Martens E.C., Gordon J.I. Functional genomic and metabilic studies of the adaptations of a prominent adult human gut symbiont, Bacteroides thetaiotaomicron, to the sucking period. J Biol Chem 2006, 281:36269-36279.
25. Blaser M.J., Falkow S. What are the consequences of the disappearing human microbiota?. Nat Rev Microbiol 2009, 7:887-894.
26. Bobek P., Nosalova V., Cerna S. Effect of pleuran (beta-glucan from Pleurotus ostreatus) in diet or drinking fluid on colitis in rats. Nahrung 2001, 45:360-363.
27. Bolam D.N., Sonnenburg J.L. Mechanistic insight into polysaccharide use within the intestinal microbiota. Gut Microbes 2011, 2(2):86-90.
28. Borody T.J., Khoruts A. Fecal microbiota transplantation and emerging applications. Nat Rev Gastroenterol Hepatol 2012, 9:88-96.
29. Brown A.J., Goldsworthy S.M., Barnes A.A., Eilert M.M., Tcheang L., Daniels D., et al. The orphan G protein-coupled receptors GPR41 and GPR43 are activated by propionate and other short chain carboxylic acids. J Biol Chem 2003, 278:11312-11319.
30. Brown C.T., Davis-Richardson A.G., Giongo A., Gano K.A., Crabb D.B., Mukherjee N., et al. Gut microbiome metagenomics analysis suggests a functional model for the development of autoimmunity for type 1 diabetes. PLoS One 2011, 6(10):e25782.
31. Buonocore S., Ahern P.P., Uhlig H.H., Ivanov I.I., Littman D.R., Maloy K.J., et al. Innate lymphoid cells drive interleukin-23-dependent innate intestinal pathology. Nature 2010, 464:1371-1375.
32. Candela M., Turroni S., Centanni M., Fiori J., Bergmann S., Hammerschmidt S., et al. Relevance of Bifidobacterium animalis subsp. lactis plasminogen binding activity in the human gastrointestinal microenvironment. Appl Environ Microbiol 2011, 77:7072-7076.
33. Cani P.D., Bibiloni R., Knauf C., Waget A., Neyrinck A.M., Delzenne N.M., et al. Changed in gut microbiota control metabolic endotoxemia-induced inflammation in high-fat diet-induced obesity and diabetes in mice. Diabetes 2008, 57:1470-1481.
34. Cani P.D., Possemier S., De Wiele T.V., Guiot Y., Everard A., Rottier O., et al. Changes in gut microbiota control inflammation in obese mice through a mechanism involving GLP-2-driven improvement of gut permeability. Gut 2009, 58:1091-1103.
35. Cario E. Toll-like receptors in inflammatory bowel diseases: a decade later. Inflamm Bowel Dis 2010, 16:1583-1597.
36. Cella M., Fuchs A., Vermi W., Facchetti F., Otero K., Lennerz J.K., et al. A human natural killer cell subset provides an innate source of IL-22 for mucosal immunity. Nature 2009, 457:722-725.
37. Cherbuy C., Honvo-Houeto E., Bruneau A., Bridonneau C., Mayeur C., Duée P., et al. Microbiota matures colonic epithelium through acoordinated induction of cell cycle-related proteins in gnotobiotic rat. Am J Physiol Gastrointest Liver Physiol 2010, 299:G348-G357.
38. Chervonsky A.V. Influence of microbial environment on autoimmunity. Nat Immunol 2010, 11:28-35.
39. Chun J., Kim K.Y., Lee J.H., Choi Y. The analysis of oral microbial communities of wild-type and Toll-like receptor 2-deficient mice using a 454 GS FLX titanium pyrosequencer. BMC Microbiol 2010, 10:101-107.
40. Claesson M.J., Cusack S., O'Sullivan O., Greene-Diniz R., Weerd H., Flannery E., et al. Composition, variability, and temporal stability of the intestinal microbiota of the elderly. Proc Natl Acad Sci U S A 2011, 108:4586-4591.
41. Collado M.C., Derrien M., Isolauri E., de Vos W.M., Salminen S. Intestinal integrity and Akkermansia muciniphila, a mucin-degrading member of the intestinal microbiota present in infants, adults, and the elderly. Appl Environ Microbiol 2007, 73:7767-7770.
42. Collier-Hyams L.S., Sloane V., Batten B.C., Neish A.S. Cutting edge: bacterial modulation of epithelial signaling via changes in neddylation of cullin-1. J Immunol 2005, 175:4194-4198.
43. Cong Y., Feng T., Fujihashi K., Schoeb T.R., Elson C.O. A dominant, coordinated T regulatory cell-IgA response to the intestinal microbiota. Proc Natl Acad Sci 2009, 106:19256-19261.
44. Conterno L., Fava F., Viola R., Tuohy K.M. Obesity and the gut microbiota:does up-regulating colonic fermentation protect against obesity and metabolic disease?. Genes Nutr 2011, 6:241-260.
45. Costello E.K., Lauber C.L., Hamady M., Fierer N., Gordon J.I., Knight R. Bacterial community variation in human body habitats across space and time. Science 2009, 326:1694-1697.
46. Croix J.A., Bhatia S., Gaskins H.R. Inflammatory cues modulate the expression of secretory product genes, Golgi sulfotransferases and sulfomucin production in LS174T cells. Exp Biol Med 2011, 236:1402-1412.
47. De Filippo C., Cavalieria D., Di Paolab M., Ramazzottic M., Poulletd J.B., Massartd S., et al. Impact of diet in shaping gut microbiota revealed by a comparative study in children from Europe and rural Africa. Proc Natl Acad Sci U S A 2010, 107:14691-14697.
48. de Roock S., van Elk M., Hoekstra M.O., Prakken B.J., Rijkers G.T., de Kleer I.M. Gut derived lactic acid bacteria induce strain specific CD4+T cell responses in human PBMC. Clin Nutr 2011, 30:845-851.
49. DeFranco A.L., Yarovinsky F., Hooper L.V. Gammadelta intraepithelial lymphocytes are essential mediators of host-microbial homeostasis at the intestinal mucosal surface. Proc Natl Acad Sci U S A 2011, 108:8743-8748.
50. Demir G., Liein H.O., Mandel-molinas N., Tuzuner N. Beta glucan induces profileration and activation of monocytes in peripheral blood of patients with advanced breast cancer. Int Immunopharmacol 2007, 7(1):113-116.
51. Denning T.L., Norris B.A., Medina-Contreras O., Manicassamy S., Geem D., Madan R., et al. Functional specializations of intestinal dendritic cell and macrophage subsets that control Th17 and regulatory T cell responses are dependent on the T cell/APC ratio, source of mouse strain, and regional localization. J Immunol 2011, 187:733-747.
52. Derrien M., Collado M.C., Ben-Amor K., Salminen S., de Vos W.M. The Mucin degrader Akkermansia muciniphila is an abundant resident of human intestinal tract. Appl Environ Microbiol 2008, 74:1646-1648.
53. Dethlefsen L., McFall-Ngai M., Relman D.A. An ecological and evolutionary perspective on human-microbe mutualism and disease. Nature 2007, 449:811-818.
54. Dethlefsen L., Huse S., Sogin M.L., Relman D.A. The pervasive effects of an antibiotic on the human gut microbiota, as revealed by deep 16s rRNA sequencing. PLoS Biol 2008, 6(11):e280.
55. Devereux G. The increase in the prevalence of asthma and allergy: food for thought. Nat Rev Immunol 2006, 6:869-874.
56. Dodd D., Mackie R.I., Cann I.K. Xylan degradation, a metabolic property shared by rumen and human colonic Bacteroidetes. Mol Microbiol 2011, 79(2):292-304.
57. Duncan S.H., Holtrop G., Lobley G.E., Calder A.G., Stewart C.S., Flint H.J. Contribution of acetate to butyrate formation by human faecal bacteria. Br J Nutr 2004, 91:915-923.
58. Duncan S.H., Louis P., Flint H.J. Lactate-utilizing bacteria, isolated from human feces, that produce butyrate as a major fermentation product. Appl Environ Microbiol 2004, 70(10):5810-5817.
59. Duncan S.H., Belenguer A., Holtrop G., Johnstone A.M., Flint H.J., Lobley G.E. Reduced dietary intake of carbohydrates by obese subjects results in decreased concentrations of butyrate and butyrate-producing bacteria in feces. Appl Environ Microbiol 2007, 73:1073-1078.
60. Duncan S.H., Lobley G.E., Holtrop G., Ince J., Johnstone A.M., Louis P., et al. Human colonic microbiota associated with diet, obesity and weight loss. Int J Obes (Lond) 2008, 32:1720-1724.
61. Dupaul-Chicoine J., Yeretssian G., Doiron K., Bergstrom K.S., McIntire C.R., LeBlanc P.M., et al. Control of intestinal homeostasis, colitis, and colitis-associated colorectal cancer by the inflammatory caspases. Immunity 2010, 32:367-378.
62. Eckburg P.B., Bik E.M., Bernstein C.N., Purdom E., Dethlefsen L., Sargent M., et al. Diversity of the human intestinal microbial flora. Science 2005, 308:1635-1638.
63. Elinav E., Strowig T., Kau A.L., Henao-Mejia J., Thaiss C.A., Booth C.J., et al. NLRP6 inflammasome regulates colonic microbial ecology and risk for colitis. Cell 2011, 145:745-757.
64. Elinav E., Strowig T., Henao-Mejia J., Flavell R.A. Regulation of the antimicrobial response by NLR proteins. Immunity 2011, 34(5):665-679.
65. Fahey G.C., Barry K.A., Swanson K.S. Age-related changes in nutrient utilization by companion animals. Annu Rev Nutr 2008, 28:425-445.
66. Faith J.J., McNulty N.P., Rey F.E., Gordon J.I. Predicting a human gut microbiota's response to diet in gnotobiotic mice. Science 2011, 333:101-103.
67. Fallani M., Amarri S., Uusijarvi A., Adam R., Khanna S., Aguilera M., et al. Determinants of the human infant intestinal microbiota after the introduction of first complementary foods in infant samples from five European centres. Microbiology 2011, 157:1385-1392.
68. Feng T., Wang L., Schoeb T.R., Elson C.O., Cong Y. Microbiota innate stimulation is a prerequisite for T cell spontaneous proliferation and induction of experimental colitis. J Exp Med 2010, 207:1321-1332.
69. Ferreira R.B., Gill N., Willing B.P., Antunes L.C., Russell S.L., Croxen M.A., et al. The intestinal microbiota plays a role in Salmonella induced colitis independent of pathogen colonization. PLoS One 2011, 6:e20338.
70. Flint H.J., Bayer E.A., Rincon M.T., Lamed R., White B.A. Polysaccharide utilization by gut bacteria: potential for new insights from genomic analysis. Nat Rev Microbiol 2008, 6:121-131.
71. Foligne B., Zoumpopoulou G., Dewulf J., Ben Younes A., Chareyre F., Sirard J.C., et al. A key role of dendritic cells in probiotic functionality. PLoS One 2007, 2(3):e313.
72. Frank D.N., Amand A.L.S., Feldman R.A., Boedeker E.C., Harpaz N., Pace N.R. Molecular-phylogenetic characterization of microbial community imbalances in human inflammatory bowel diseases. Proc Natl Acad Sci U S A 2007, 104:13780-13785.
73. Fraser-Liggett C.M. Insights on biology and evolution from microbial genome sequencing. Genome Res 2005, 15:1603-1610.
74. Fritz J.H., Rojas O.L., Simard N., McCarthy D.D., Hapfelmeier S., Rubino S., et al. Acquisition of a multifunctional IgA+plasma cell phenotype in the gut. Nature 2011, 481:199-203.
75. Fritz T., Niederreiter L., Adolph T., Blumberg R.S., Kaser A. Crohn's disease: NOD2, autophagy and ER stress converge. Gut 2011, 60(11):1580-1588.
76. Fujiya M., Musch M.W., Nakagawa Y., Hu S., Alverdy J., Kohgo Y., et al. The Bacillus subtilis quorum-sensing molecule CSF contributes to intestinal homeostasis via OCTN2, a host cell membrane transpoter. Cell Host Microbe 2007, 1:299-308.
77. Gaboriau-Routhiau V., Rakotobe S., LeD́cuyer E., Mulder I., Lan A., Bridonneau C., et al. The key role of segmented filamentous bacteria in the coordinated maturation of gut helper T cell responses. Immunity 2009, 31:677-689.
78. Gallorini S., Berti F., Mancuso G., Cozzi R., Tortoli M., Volpini G., et al. Toll-like receptor 2 dependent immunogenicity of glycoconjugate vaccines containing chemically derived zwitterionic polysaccharides. Proc Natl Acad Sci U S A 2009, 106:17481-17486.
79. Galvez J., Rodriguez-Cabezas M.E., Zariuelo A. Effects of dietary fiber on inflammatory bowel disease. Mol Nutr Food Res 2005, 49:601-608.
80. Gerken T., Girard C.A., Tung Y.C., Webby C.J., Saudek V., Hewitson K.S., et al. The obesity-associated FTO gene encodes a 2-oxoglutarate-dependent nucleic acid demethylase. Science 2007, 318:1469-1472.
81. Gill S.R., Pop M., Deboy R.T., Eckburg P.B., Turnbaugh P.J., Samuel B.S., et al. Metagenomic analysis of the human distal gut microbiome. Science 2006, 312:1355-1359.
82. Goodlad R.A., Ratcliffe B., Fordham P., Wright N.A. Does dietary fibre stimulate intestinal epithelial cell proliferation in germ free rats?. Gut 1989, 30:820-825.
83. Goodman A.L., McNulty N.P., Zhao Y., Leip D., Mitra R.D., Lozupone C.A. Identifying Genetic Determinants Needed to Establish a Human Gut Symbiont in Its Habitat. Cell Host & Microbe 2009, 6:279-289.
84. Goodman A.L., Kallstrom G., Faith J.J., Reyes A., Moore A., Dantas G., et al. Extensive personal human gut microbiota culture collections characterized and manipulated in gnotobiotic mice. Proc Natl Acad Sci U S A 2011, 108:6252-6257.
85. Guigoz Y., DoreD́ J., Schiffrin J. The inflammatory status of old age can be nurtured from the intestinal environment. Curr Opin Clin Nutr Metab Care 2008, 11:13-20.
86. Han D.W. Intestinal endotoxemia as a pathogenetic mechanism in liver failure. World J Gastroenterol 2002, 8:961-965.
87. Hasegawa M., Yamazaki T., Kamada N., Tawaratsumida K., Kim Y.G., Nunez G., et al. Nucleotide-binding oligomerization domain 1 mediates recognition of Clostridium difficile and induces neutrophil recruitment and protection against the pathogen. J Immunol 2011, 186:4872-4880.
88. Hehemann J.H., Correc G., Barbeyron T., Helbert W., Czjzek M., Michel G. Transfer of carbohydrate-active enzymes from marine bacteria to Japanese gut microbiota. Nature 2010, 464:908-912.
89. Henao-mejia J., Elinav E., Jin C., Hao L., Mehal W.Z., Strowig T., et al. Inflammasone-mediated dysbiosis regulates progression of NAFLD and obesity. Nature 2012, 482:179-185.
90. Hess M., Sczyrba A., Egan R., Kim T., Chokhawala H., Schroth G., et al. Metagenomic discovery of biomass-degrading genes and genomes from cow rumen. Science 2011, 331:463-467.
91. Hill D.A., Artis D. Intestinal bacteria and the regulation of immune cell homeostasis. Annu Rev Immunol 2010, 28:623-667.
92. Hill D.A., Hoffmann C., Abt M.C., Du Y., Kobuley D., Kirn T.J., et al. Metagenomic analyses reveal antibiotic-induced temporal and spatial changes in intestinal microbiota with associated alterations in immune cell homeostasis. Mucosal Immunol 2010, 3:148-158.
93. Hofer U., Speck R.F. Disturbance of the gut-associated lymphoid tissue is associated with disease progression in chronic HIV infection. Semin Immunopathol 2009, 31:255-266.
94. Hong F., Yan J., Baran J.T., Allendorf D.J., Hansen R.D., Ostroff G.R., et al. Mechanism by which orally administered beta-1,3-glucans enhance the tumoricidal activity of antitumor monoclonal antibodies in murine tumor models. J Immunol 2004, 173:797-806.
95. Hooper L.V., Macpherson A.J. Immune adaptations that maintain homeostasis with the intestinal microbiota. Nat Rev Immunol 2010, 10:159-169.
96. Hooper L.V., Wong M.H., Thelin A., Hansson L., Falk P.G., Gordon J.I. Molecular analysis of commensal host-microbial relationships in the intestine. Science 2001, 291:881-884.
97. Hrncir T., Stepankova R., Kozakova H., Hudcovic T., Tlaskalova-Hogenova H. Gut microbiota and lipopolysaccharide content of the diet influence development of regulatory T cells: studies in germ-free mice. BMC Immunol 2008, 9:65-75.
98. Hu B., Elinava E., Huber S., Booth C.J., Strowig T., Jin C., et al. Inflammation-induced tumorigenesis in the colon is regulated by caspase-1 and NLRC4. Proc Natl Acad Sci U S A 2010, 107:21635-21640.
99. Huang G., Wang Y., Vogel P., Kanneganti T., Otsu K., Chi H. Signaling via the kinase p38α programs dendritic cells to drive Th17 differentiation and antuimmune inflammation. Nat Immunol 2012, 13:152-161.
100. Huber S., Flavell R.A. Checks and balances: IL-23 in the intestine. Immunity 2010, 150-152.
101. Huber S., Gagliani N., Esplugues E., O'Connor W.J., Huber F.J., Chaudhry A., et al. Cells express interleukin-10 receptor and are controlled by Foxp3+ and Foxp3+ regulatory CD+4T cells in an interlenkin-10-dependent manner. Immunity 2011, 34:554-565.
102. Ichimura A., Hirasawa A., Poulain-Godefroy O., Bonnefond A., Hara T., Yengo L., et al. Dysfunction of lipid sensor GPR120 leads to obesity in both mouse and human. Nature 2012, 483:350-354.
103. Igyártó B.Z., Haley K., Ortner D., Bobr A., Gerami-Nejad M., Edelson B.T., et al. Skin-resident murine dendritic cell subsets promote distinct and opposing antigen-specific T helper cell responses. Immunity 2011, 35:260-272.
104. Ismail A.S., Hooper L.V. Epithelial cells and their neighbors. IV. Bacterial contributions to intestinal epithelial barrier integrity. Am J Physiol Gastrointest Liver Physiol 2005, 289:G779-G784.
105. Ismail A.S., Behrendt C.L., Hooper L.V. Reciprocal interactions between commensal bacteria and gamma delta intraepithelial lymphocytes during mucosal injury. J Immunol 2009, 182:3047-3054.
106. Ismail A.S., Severson K.M., Vaishnava S., Behrendt C.L., Yu X., Benjamin J.L., et al. γδ intraepithelial lymphocytes are essential mediators of host-microbial homeostasis at the intestinal mucosal surface. Proc Natl Acad Sci U S A 2011, 108:8743-8748.
107. Ivanov I.I., Littman D.R. Segmented filamentous bacteria take the stage. Mucosal Immunol 2010, 3:209-212.
108. Ivanov I.I., Frutos R.D, Manel N., Yoshinaga K., Rifkin D.B., Sartor R.B., et al. Specific microbiota direct the differentiation of IL-17-producing T-helper cells in the mucosa of the small intestine. Cell Host Microbe 2008, 4:337-349.
109. Ivanov I.I., Atarashi K., Manel N., Brodie E.L., Shima T., Karaoz U., et al. Induction of intestinal Th17 cells by segmented filamentous bacteria. Cell 2009, 139:485-498.
110. Izcue A., Coombes J.L., Powrie F. Regulatory lymphocytes and intestinal inflammation. Annu Rev Immunol 2009, 27:313-338.
111. Jalanka-Tuovinen J., Salonen A., Nikkilä J., Immonen O., Kekkonen R., Lahti L., et al. Intestinal microbiota in healthy adults: temporal analysis reveals individual and common core and relation to intestinal symptoms. PLoS One 2011, 6(7):e23035.
112. Jarchum I., Liu M., Lipuma L., Pamer E.G. Toll-like receptor 5 stimulation protects mice from acute Clostridium difficile colitis. Infect Immun 2011, 79:1498-1503.
113. Jeffery I.B., O'Toole P.W., Öhman L., Claesson M.J., Deane J., Quigley E.M., et al. An irritable bowel syndrome subtype defined by species-specific alterations in faecal microbiota. Gut 2012, 61:997-1006.
114. Jernberg C., Lofmark S., Edlund C., Jansson J.K. Long-term ecological impacts of antibiotic administration on the human intestinal microbiota. ISME J 2007, 1:56-66.
115. Jernberg C., Lofmark S., Edlund C., Jansson J.K. Long-term impacts of antibiotic exposure on the human intestinal microbiota. Microbiology 2010, 156:3216-3223.
116. Jha R., Rossnagel B., Pieper R., Van Kessel A., Leterme P. Barley and oat cultivars with diverse carbohydrate composition alter ileal and total tract nutrient digestibility and fermentation metabolites in weaned piglets. Animal 2010, 4:724-731.
117. Johansson M.E., Phillipson M., Petersson J., Velcich A., Holm L., Hansson G.C. The inner of the two Muc2 mucin-dependent mucus layers in colon is devoid of bacteria. Proc Natl Acad Sci U S A 2008, 105:15064-15069.
118. Jumpertz R., Le D.S., Turnbaugh P.J., Trinidad C., Bogardus C., Gordon J.I., et al. Energy-balance studies reveal associations between gut microbes, caloric load, and nutrient absorption in humans. Am J Clin Nutr 2011, 94:58-65.
119. Kaci G., Lakhdari O., Dore J., Ehrlich D., Renault P., Blottiere H.M., et al. Inhibition of the NF-kB pathway in human intestinal epithelial cell by commensal Streptococcus salivarius. Appl Environ Microbiol 2011, 77:4681-4684.
120. Karaki S., Tazoe H., Hayashi H., Kashiwabara H., Tooyama K., Suzuki Y., et al. Expression of the short-chain fatty acid receptor, GPR43, in the human colon. J Mol Histol 2008, 39:135-142.
121. Karczewski J., Troost F.J., Konings I., Dekker J., Kleerebezem M., Brummer R.J., et al. Regulation of human epithelial tight junction proteins by Lactobacillus plantarum in vivo and protective effects on the epithelial barrier. Am J Physiol Gastrointest Liver Physiol 2010, 298:G851-G859.
122. Kaser A., Lee A.H., Franke A., Glickman J.N., Zeissig S., Tilg H., et al. XBP1 links ER stress to intestinal inflammation and confers genetic risk for human inflammatory bowel disease. Cell 2008, 134:743-756.
123. Kaser A., Martinez-Naves E., Blumberg R.S. Endoplasmic reticulum stress: implications for inflammatory bowel disease pathogenesis. Curr Opin Gastroenterol 2010, 26:318-326.
124. Kaser A., Zeissig S., Blumberg R.S. Inflammatory bowel disease. Annu Rev Immunol 2010, 28:573-621.
125. Kau A.L., Ahern P.P., Griffin N.W., Goodman A.L., Gordon J.I. Human nutrition, the gut microbiome and the immune system. Nature 2011, 474:327-336.
126. Kelley D.R., Liu B., Delcher A.L., Pop M., Salzberg S.L. Gene prediction with Glimmer for metagenomic sequences augmented by classification and clustering. Nucleic Acids Res 2012, 40(1):e9.
127. Kelly D., Campbell J.I., King T.P., Grant G., Jansson E.A., Coutts A.G., et al. Commensal anaerobic gut bacteria attenuate inflammation by regulating nuclear-cytoplasmic shuttling of PPAR-γand RelA. Nat Immunol 2004, 5:104-112.
128. Kendal A.R., Chen Y., Regateiro F.S., Ma J., Adams E., Cobbold S.P., et al. Sustained suppression by Foxp3+ regulatory T cells is vital for infectious transplantation tolerance. J Exp Med 2011, 208:2043-2053.
129. Kerckhoffs A.P., Ben-Amor K., Samsom M., van der Rest M.E., de Vogel J., Knol J., et al. Molecular analysis of faecal and duodenal samples reveals significantly higher prevalence and numbers of Pseudomonas aeruginosa in irritable bowel syndrome. J Med Microbiol 2011, 60:236-245.
130. Kimura I., Inoue D., Maeda T., Hara T., Ichimura A., Miyauchi S., et al. Short-chain fatty acids and ketones directly regulate sympathetic nervous system via G protein-coupled receptor 41 (GPR41). Proc Natl Acad Sci U S A 2011, 108:8030-8035.
131. Kinnebrew M.A., Ubeda C., Zenewicz L.A., Smith N., Flavell R.A., Pamer E.G. Bacterial flagellin stimulates Toll-like receptor 5-dependent defense against vancomycin-resistant Enterococcus infection. J Infect Dis 2010, 201:534-543.
132. Kleerebezem M., Boekhorst J., van Kranenburg R., Molenaar D., Oscar Kuipers O.P., Leer R., et al. Complete genome sequence of Lactobacillus plantarum WCFS1. Prod Natl Acad Sci USA 2003, 100:1990-1995.
133. Kobayashi K., Hernandez L.D., Galán J.E., Janeway C.A.J., Medzhitov R., Flavell R.A. IRAK-M is a negative regulator of Toll-like receptor signaling. Cell 2002, 110:191-202.
134. Koren S., Treangen T.J., Pop M. Bambus 2: scaffolding metagenomes. Bioinformatics 2011, 27:2964-2971.
135. Koslowski M.J., Beisner J., Stange E.F., Wehkamp J. Innate antimicrobial host defense in small intestinal Crohn's disease. Int J Med Microbiol 2010, 300:34-40.
136. Kreisman L.C., Cobb B.A. Glycoantigens induce human peripheral Tr1 cell differentiation with gut-homing specialization. J Biol Chem 2011, 286:8810-8818.
137. Kuhbacher T., Ott S.J., Helwig U., Mimura T., Rizzello F., Kleessen B., et al. Bacterial and fungal microbiota in relation to probiotic therapy (VSL#3) in pouchitis. Gut 2006, 55:833-841.
138. Kumar A., Wu H., Collier-Hyams L.S., Kwon Y.M., Hanson J.M., Neish A.S. The bacterial fermentation product butyrate influences epithelial signaling via reactive oxygen species-mediated changes in cullin-1 neddylation. J Immunol 2009, 182:538-546.
139. Kuwahara T., Ogura Y., Oshima K., Kurokawa K., Ooka T., Hirakawa, et al. The lifestyle of the segmented filamentous bacterium: a non-culturable gut-associated immunostimulating microbe inferred by whole-genome sequencing. DNA Res 2011, 18:291-303.
140. Lakhdari O., Tap J., Béguet-Crespel F., Le Roux K., de Wouters T., Cultrone A., et al. Identification of NF-κB modulation capabilities within human intestinal commensal bacteria. J Biomed Biotechnol 2011, 10.1155/2011/282356.
141. Lara-Villoslada F., de Haro O., Camuesco D., Comalada M., Velasco J., Zarzuelo A., et al. Short-chain fructooligosaccharides, in spite of being fermented in the upper part of the large intestine, have anti-inflammatory activity in the TNBS model of colitis. Eur J Nutr 2006, 45:418-425.
142. Larsson E., Tremaroli V., Lee Y.S., Koren O., Nookaew I., Fricker A., et al. Analysis of gut microbial regulation of host gene expression along the length of the gut and regulation of gut microbial ecology through MyD88. Gut 2012, 61:1124-1131.
143. Lathrop S.K., Bloom S.M., Rao S.M., Nutsch K., Lio C., Santacruz N., et al. Peripheral education of the immune system by colonic commensal microbiota. Nature 2011, 478:250-254.
144. Le Poul E., Loison C., Struyf S., Springael J., Lannoy V., Decobecq M., et al. Functional characterization of human receptors for short chain fatty acids and their role in polymorphonuclear cell activation. J Biol Chem 2003, 278:25481-25489.
145. Lee Y.K., Mazmanian S.K. Has the microbiota played a critical role in the evolution of the adaptive immune system. Science 2010, 330:1768-1773.
146. Lee Y.K., Menezes J.S., Umesaki Y., Mazmanian S. Proinflaamatory T-cell responses to gut microbiota promote experimental autoimmune encephalomyelitis. Proc Natl Acad Sci U S A 2011, 108(Suppl. 1):4615-4622.
147. Leppkes M., Becker C., Ivanov I.I., Hirth S., Wirtz S., Neufert C., et al. RORγ-expressing Th17 cells induce murine chronic intestinal inflammation via redundant effects of IL-17A and IL-17F. Gastroenterology 2009, 136:257-267.
148. Letran S.E., Lee S.J., Atif S.M., Flores-Langarica A., Uematsu S., Akira S., et al. TLR5-deficient mice lack basal inflammatory and metabolic defects but exhibit impaired CD4 T cell responses to a flagellated pathogen. J Immunol 2011, 186:5406-5412.
149. Ley R.E., Backhed F., Turnbaugh P.J., Lozupone C.A., Knight R.D., Gordon J.I. Obesity alters gut microbial ecology. Proc Natl Acad Sci U S A 2005, 102:11070-11075.
150. Ley R.E., Turnbaugh P.J., Klein S., Gordon J.I. Human gut microbes associated with obesity. Nature 2006, 444:1022-1023.
151. Li M. Co-variation analysis of human gut microbial structure and host global metabolism. Thesis for Philosophy Degree at Shanghai Jiao Tong University, 2009.
152. Li M., Wang B., Zhang M., Rantalainen M., Wang S., Zhou H., et al. Symbiotic gut microbes modulate human metabolic phenotypes. Proc Natl Acad Sci U S A 2008, 105:2117-2122.
153. Li F., Hullar M.A., Schwarz Y., Lampe J.W. Human gut bacterial communities are altered by addition of cruciferous vegetables to a controlled fruit- and vegetable-free diet. J Nutr 2009, 139:1685-1691.
154. Li B., Cai Y., Qi C., Hansen R., Ding C., Mitchell T.C., et al. Orally administered particulate β-glucan modulates tumor-capturing dendritic cells and improves antitumor T-cell responses in cancer. Clin Cancer Res 2010, 15:5153. 10.1158/1078-0432.
155. Li P., Yu Q., Ye X., Wang Z., Yang Q. Lactobacillus S-layer protein inhibition of Salmonella-induced reorganization of the cytoskeleton and activation of MAPK signalling pathways in Caco-2 cells. Microbiology 2011, 157:2639-2646.
156. Li X., Chiu Y., Ismail A.S., Behrendt C.L., Wight-Carter M., Hooper L.V., et al. Mitochondrial antiviral signaling protein (MAVS) monitors commensal bacteria and induces an immune response that prevents experimental colitis. Proc Natl Acad Sci U S A 2011, 108:17390-17395.
157. Littman D.R., Pamer E.G. Role of the commensal microbiota in normal and pathogenic host immune responses. Cell Host Microbe 2011, 10:311-323.
158. Liu J. Understanding the structure shifts of gut microbiota in patients with chromic viral hepatitis B. Thesis for Master Degree at Shanghai Jiao Tong University, 2011.
159. Liu X., Wu S., Xia Y., Li X.E., Xia Y., Zhou Z.D., et al. Wingless homolog Wnt11 suppresses bacterial invasion and inflammation in intestinal epithelial cells. Am J Physiol Gastrointest Liver Physiol 2011, 301:G992-G1003.
160. Login F.H., Balmand S., Vallier A., Vincent-Monégat C., Vigneron A., Weiss-Gayet M., et al. Antimicrobial peptides keep insect endosymbionts under control. Science 2011, 334:362-365.
161. Louis P., Flint H.J. Diversity, metabolism and microbial ecology of butyrate-producing bacteria from the human large intestine. FEMS Microbiol Lett 2009, 294:1-8.
162. Louis P., Young P., Holtrop G., Flint H.J. Diversity of human colonic butyrate-producing bacteria revealed by analysis of the butyryl-CoA:acetate CoA-transferase gene. Environ Microbiol 2010, 12:304-314.
163. Lozupone C.A., Hamady M., Cantarel B.L., Coutinho P.M., Henrissat B., Gordon J.I., et al. The convergence of carbohydrate active gene repertoires in human gut microbes. Proc Natl Acad Sci U S A 2008, 105:15076-15081.
164. Luci C., Reynders A., Ivanov I.I., Cognet C., Chiche L., Chasson L., et al. Influence of the transcription factor RORgammat on the development of NKp46+cell populations in gut and skin. Nat Immunol 2009, 10:75-82.
165. MacDonald T.T., Monteleone G. Immunity, inflammation, and allergy in the gut. Science 2005, 307:1920-1925.
166. Mahowalda M.A., Reya F.E., Seedorfa H., Turnbaugha P.J., Fultonb R.S., Wollamb A., et al. Characterizing a model human gut microbiota composed of members of its two dominant bacterial phyla. Proc Natl Acad Sci U S A 2009, 106:5859-5864.
167. Maloy K.J., Kullberg M.C. IL-23 and Th17 cytokines in intestinal homeostasis. Mucosal Immunol 2008, 1:339-349.
168. Maloy K.J., Powrie F. Intersinal homeostasis and its breakdown in inflammatory bowel disease. Nature 2011, 474:298-306.
169. Manco M., Putignani L., Bottazzo G.F. Gut microbiota, lipopolysaccharides, and innate immunity in the pathogenesis of obesity and cardiovascular risk. Endocr Rev 2010, 31:817-844.
170. Manicassamy S., Reizis B., Ravindran R., Nakaya H., Salazar-Gonzalez R.M., Wang Y., et al. Activation of β-catenin in dendritic cells regulates immunity versus tolerance in the intestine. Science 2010, 329:849-853.
171. Manichanh C., Rigottier-Gois L., Bonnaud E., Gloux K., Pelletier E., Frangeul L., et al. Reduced diversity of faecal microbiota in Crohn's disease revealed by a metagenomic approach. Gut 2006, 55:205-211.
172. Marchesi J.R., Dutilh B.E., Hall N., Peters W.H., Roelofs R., Boleij A., et al. Towards the human colorectal cancer microbiome. PLoS One 2011, 6(5):e20447.
173. Marcobal A., Barboza M., Sonnenburg E.D., Pudlo N., Martens E.C., Desai P., et al. Bacteroides in the infant gut consume milk oligosaccharides via mucus-utilization pathways. Cell Host Microbe 2011, 10:1-8.
174. Mariat D., Firmesse O., Levenez F., Guimaraes V.D., Sokol H., Dore J., et al. The Firmicutes/Bacteroidetes ratio of the human microbiota changes with age. BMC Microbiol 2009, 9:123.
175. Martens E.C., Chiang H.C., Gordon J.I. Mucosal glycan forging enhances fitness and transmission of a saccarolytic human gut bacterial symbiont. Cell Host Microbe 2008, 4:447-457.
176. Martens E.C., Koropatkin N.M., Smith T.J., Gordon J.I. Complex glycan catabolismby the human gut microbiota: the Bacteroidetes Sus-like paradigm. J Biol Chem 2009, 284:24673-24677.
177. Martin F.P., Wang Y., Sprenger N., Yap I.K., Lundstedt T., Lek P., et al. Probiotic modulation of symbiotic gut microbial-host metabolic interactions in a humanized microbiome mouse model. Mol Syst Biol 2008, 4:157.
178. Martinez-Medina M., Aldeguer X., Gonzalez-Huix F., Acero D., Garcia-Gil L.J. Abnorma lmicrobiota composition in the ileocolonic mucosa of Crohn's disease patients as revealed by polymerase chain reaction-denaturing gradient gel electrophoresis. Inflamm Bowel Dis 2006, 12:1136-1145.
179. Martinon F., Chen X., Lee A., Glimcher L.H. TLR activation of the transcription factor XBP1 regulates innate immune responses in macrophages. Nat Immunol 2010, 11:411-418.
180. Maslowski K.M., Mackay C.R. Diet, gut microbiota and immune responses. Nat Immunol 2011, 12(1):5-9.
181. Maslowski K.M., Vieira A.T., Ng A., Kranich J., Sierro F., Yu D., et al. Regulation of inflammatory responses by gut microbiota and chemoattractant receptor GPR43. Nature 2009, 461:1282-1286.
182. Mazmanian S.K., Liu C.H., Tzianabos A.O., Kasper D.L. An immunomodulatory molecule of symbiotic bacteria directs maturation of the host immune system. Cell 2005, 122:107-118.
183. Mazmanian S.K., Round J.L., Kasper D.L. A microbial symbiosis factor prevents intestinal inflammatory disease. Nature 2008, 453:620-625.
184. McDole J.R., Wheeler L.W., McDonald K.G., Wang B., Konjufca V., Knoop K.A., et al. Goblet cells deliver luminal antigen to CD103+ dendritic cells in the small intestine. Nature 2012, 483:345-349.
185. McWilliam Leitch E.C., Walker A.W., Duncan S.H., Holtrop G., Flint H.J. Selective colonisation of insoluble substrates by human faecal bacteria. Environ Microbiol 2006, 72:667-679.
186. Metzler-Zebeli B.U., Zijlstra R.T., Mosenthin R., Ganzle M.G. Dietary calcium phosphate content and oat β-glucan infleunce gastrointestinal microbiota, butyrate-producing bacteria and butyrate fermentation in weaned pigs. FEMS Microbiol Ecol 2011, 75:402-413.
187. Mitsou E.K., Panopoulou N., Turunen K., Spiliotis V., Kyriacou A. Prebiotic potential of barley derived β-glucan at low intake levels: a randomised, double-blinded, placebo-controlled clinical study. Food Res Int 2010, 43:1086-1092.
188. Mizuno M., Nishitani Y., Hashimoto T., Kanazawa K. Different suppressive effects of fucoidan and lentinan on IL-8 mRNA expression in in vitro gut inflammation. Biosci Biotechnol Biochem 2009, 73:2324-2325.
189. Mizushima N., Komatsu M. Autophagy: renovation of cells and tissues. Cell 2011, 147:728-741.
190. Morland B., Midtvedt T. Phagocytosis, peritoneal influx, and enzyme activities in peritoneal macrophages from germfree, conventional, and ex-germfree mice. Infect Immun 1984, 44:750-752.
191. Motta J.P., Bermúdez-Humarán L.G., Deraison C., Martin L., Rolland C., Rousset P., et al. Food-grade bacteria expressing Elafin protect against inflammation and restore colon homeostasis. Sci Transl Med 2012, 4:158ra144.
192. Mueller S., Saunier K., Hanisch C., Norin E., Alm L., Midtvedt T., et al. Differences in fecal microbiota in different European study populations in relation to age, gender, and country: a cross-sectional study. Appl Environ Microbiol 2006, 72:1027-1033.
193. Murphy E.F., Cotter P.D., Healy S., Marques T.M., O'Sullivan O., Fouhy F., et al. Composition and energy harvesting capacity of the gut microbiota: relationship to diet, obesity and time in mouse models. Gut 2010, 59:1635-1642.
194. Nam Y.D., Jung M.J., Roh S.W., Kim M.S., Bae J.W. Comparative analysis of korean human gut microbiota by barcoded pyrosequencing. PLoS One 2011, 6(7):e22109.
195. Neish A.S., Gewirtz A.T., Zeng H., Young A.N., Hobert M.E., Karmali V., et al. Prokaryotic regulation of epithelial responses by inhibition of IκB-α ubiquitination. Science 2000, 289:1560-1563.
196. Nenci A., Becker C., Wullaert A., Gareus R., van Loo G., Danese S., et al. Epithelial NEMO links innate immunity to chronic intestinal inflammation. Nature 2007, 446:557-561.
197. Nicholson J.K., Holmes E., Wilson I.D. Gut microorganisms, mammalian metabolism and personalized health care. Nat Rev Microbiol 2005, 3:431-438.
198. Nikitas G., Deschamps C., Disson O., Niault T., Cossart P., Lecuit M. Transcytosis of Listeria monocytogenes across the intestinal barrier upon specific targeting of goblet cell accessible E-cadherin. J Exp Med 2011, 208:2263-2277.
199. O'Shea C.J., Sweeney T., Lynch M.B., Gahan D.A., Callan J.J., O'Doherty J.V. Effect of β-glucans contained in barley- and oat-based diets and exogenous enzyme supplementation on gastrointestinal fermentation of finisher pigs and subsequent manure odor and ammonia emissions. J Anim Sci 2010, 88:1411-1420.
200. O'Connell Motherway M., Zomer A., Leahy S.C., Reunanen J., Bottacini F., Claesson M.J., et al. Functional genome analysis of Bifidobacterium breve UCC2003 reveals type IVb tight adherence (Tad) pili as an essential and conserved host-colonization factor. Proc Natl Acad Sci U S A 2011, 108:11217-11222.
201. O'Mahony C., Scully P., O'Mahony D., Murphy S., O'Brien F., Lyons A., et al. Commensal-induced regulatory T cells mediate protection against pathogenstimulated NF-kappaB activation. PLoS Pathog 2008, 4:e1000112.
202. Pabst O., Mowat A.M. Oral tolerance to food protein. Mucosal Immunol 2012, 5:232-239.
203. Payne A.N., Chassard C., Zimmermann M., Müller P., Stinca S., Lacroix C. The metabolic activity of gut microbiota in obese children is increased compared with normal-weight children and exhibits more exhaustive substrate utilization. Nutr Diabetes 2011, 1:e12.
204. Penders J., Stobberingh E.E., van den Brandt P.A., Thijs C. The role of the intestinal microbiota in the development of atopic disorders. Allergy 2007, 62:1223-1226.
205. Pennisi E. Body's hardworking microbes get some overdue respect. Science 2010, 330:6011.
206. Petnicki-Ocwieja T., Hrncir T., Liu Y.J., Biswas A., Hudcovic T., Tlaskalova-Hogenova H., et al. Nod2 is required for the regulation of commensal microbiota in the intestine. Proc Natl Acad Sci U S A 2009, 106:15813-15818.
207. Pieper R., Jha R., Rossnagel B., Van Kessel A., Souffrant W.B., Leterme P. Effect of barley and oat cultivars with different carbohydrate compositions on the intestnal bacterial communities in weaned piglets. FEMS Microbiol Ecol 2008, 66:556-566.
208. Pieper R., Bindelle J., Rossnagel B., Van Kessel A., Leterme P. Effect of carbohydrate composition in barley and oat cultivars on microbial ecophysiology and proliferation of Salmonella enterca in an in vitro model of the porcine gastrointestinal tract. Appl Environ Microbiol 2009, 75:7006-7016.
209. Prakash T., Oshima K., Morita H., Fukuda S., Imaoka A., Kumar N., et al. Complete genome sequences of rat and mouse segmented filamentous bacteria, a potent inducer of th17 cell differentiation. Cell Host Microbe 2011, 10:273-284.
210. Pryde S.E., Duncan S.H., Hold G.L., Stewart C.S., Flint H.J. The microbiology of butyrate formation in the human colon. FEMS Microbiol Lett 2002, 217:133-139.
211. Qi C., Cai Y., Gunn L., Ding C., Li B., Kloecker G., et al. Differential pathways regulating innate and adaptive antitumor immune responses by particulate and soluble yeast-derived β-glucans. Blood 2011, 117:6825-6836.
212. Qin J., Li R., Raes J., Arumugam M., Burgdorf K.S., Manichanh C. Human gut microbial gene catalogue established by metagenomic sequencing. Nature 2010, 464:59-65.
213. Rajilić-Stojanović M., Heiliq H.G., Molenaar D., Kajander K., Surakka A., Smidt H., et al. Development and application of the human intestinal tract chip, a phylogenetic microarray: analysis of universally conserved phylotypes in the abundant microbiota of young and elderly adults. Environ Microbiol 2009, 11:1736-1751.
214. Rehman A., Lepage P., Nolte A., Hellmig S., Schreiber S., Ott S.J. Transcriptional activity of the dominant gut mucosal microbiota in chronic inflammatory bowel disease patients. J Med Microbiol 2010, 59:1114-1122.
215. Reilly P., Sweeney T., Smith A.G., Pierce K.M., Gahan D.A., Callan J.J., et al. The effects of cereal-derived β-glucans and enzyme supplementatiation on intestinal microbiota, nutrient digestibility and mineral metabolism in pigs. Livest Sci 2010, 133:144-147.
216. Rey F.E., Faith J.J., Bain J., Muehlbauer M.J., Stevens R.D., Newgard C.B., et al. Dissecting the in vivo metabolic potential of two human gut acetogens. J Biol Chem 2010, 285:22082-22090.
217. Rice P.J., Adams E.L., Ozment-Skelton T., Gonzalez A.J., Goldman M.P., Lockhart B.E., et al. Oral delivery and gastrointestinal absorption of soluble glucans stimulate increased resistance to infectious challenge. J Pharmacol Exp Ther 2005, 314(3):1079-1086.
218. Rop O., Mlcek J., Jurikova T. Beta-glucans in higher fungi and their health effects. Nutr Rev 2009, 67:624-631.
219. Round J.L., Mazmanian S.K. The gut microbiota shapes intestinal immune responses during health and disease. Nat Rev Immunol 2009, 9:313-323.
220. Round J.L., Mazmanian S.K. Inducible Foxp3+ regulatory T-cell development by a commensal bacterium of the intestinal microbiota. Proc Natl Acad Sci U S A 2010, 107:12204-12209.
221. Round J.L., O'Connell R.M., Mazmanian S.K. Coordination of tolerogenic immune responses by the commensal microbiota. J Autoimmun 2009, 34:220-225.
222. Round J.L., Lee S.M., Li J., Tran G., Jabri B., Chatila T.A., et al. The Toll-like receptor 2 pathway establishes colonization by a commensal of the human microbiota. Science 2011, 332:974-977.
223. Ruan Q., Kameswaran V., Zhang Y., Zheng S., Sun J., Wang J., et al. The Th17 immune response is controlled by the Rel-RORγ-RORγT transcriptional axis. J Exp Med 2011, 208:2321-2333.
224. Saiful Islam K.B., Fukiya S., Hagio M., Fujii N., Ooka T., Ogura Y., et al. Bile acid is a host factor that regulates the composition of the cecal microbiota in rats. Gastroenterology 2011, 141:1773-1781.
225. Salcedo R., Worschech A., Cardone M., Jones Y., Gyulai Z., Dai R., et al. MyD88-mediated signaling prevents development of adenocarcinomas of the colon: role of interleukin 18. J Exp Med 2010, 207:1625-1636.
226. Salonen A., Vos W.M., Palva A. Gastrointestinal microbiota in irritable bowel syndrome: present state and perspectives. Microbiology 2010, 156:3205-3215.
227. Samuel B.S., Gordon J.I. A humanized gnotobiotic mouse model of host-archaeal-bacterial mutualism. Proc Natl Acad Sci U S A 2006, 103:10011-10016.
228. Samuel B.S., Shaito A., Motoike T., Rey F.E., Backhed F., Manchester J.K., et al. Effects of the gut microbiota on host adiposity are modulated by the short-chain fatty-acid binding G protein-coupled receptor, Gpr41. Proc Natl Acad Sci U S A 2008, 105:16767-16772.
229. Sanchez B., Urdaci M.C., Margolles A. Extracellular proteins secreted by probiotic bacteria as mediators of effects that promote mucosa-bacteria interactions. Microbiology 2010, 156:3232-3242.
230. Sanos S.L., Bui V.L., Mortha A., Oberle K., Heners C., Johner C., et al. RORgammat and commensal microflora are required for the differentiation of mucosal interleukin 22 producing NKp46+cell. Nat Immunol 2009, 10:83-91.
231. Sansonetti P.J., Medzhitov R. Learning tolerance while fighting ignorance. Cell 2009, 138:416-420.
232. Santacruz A., Collado M.C., Garcia-Valdes L., Segura M.T., Martin-Lagos J.A., Anjos T., et al. Gut microbiota composition is associated with body weight, weight gain and biochemical parameters in pregnant women. Br J Nutr 2010, 104:83-92.
233. + innate lymphoid cells regulate intestinal homeostasis by integrating negative signals from the symbiotic microbiota. Nat Immunol 2011, 12:320-326.
234. Scanlan P.D., Marchesi J.R. Micro-eukaryotic diversity of the human distal gut microbiota: qualitative assessment using culture-dependent and -independent analysis of faeces. ISME J 2008, 2:1183-1193.
235. Schwiertz A., Taras D., Schäfer K., Beijer S., Bos N.A., Donus C., et al. Microbiota and SCFA in lean and overweight healthy subjects. Obesity 2010, 18:190-195.
236. Sczesnak A., Segata N., Qin X., Gevers D., Petrosino J.F., Huttenhower C., et al. The genome of th17 cell-inducing segmented filamentous bacteria reveals extensive auxotrophy and adaptations to the intestinal environment. Cell Host Microbe 2011, 10:260-272.
237. Sekirov I., Russell S., Antunes C., Finlay B.B. Gut microbiota in health and disease. Physiol Rev 2010, 90:859-904.
238. Seksik P., Sokol H., Lepage P., Vasquez N., Manichanh C., Mangin I., et al. The role of bacteria in onset and perpetuation of inflammatory bowel disease. Aliment Pharmacol Ther 2006, 24:11-18.
239. Shale M., Ghosh S. How intestinal epithelial cells tolerise dendritic cells and its relevance to inflammatory bowel disease. Gut 2009, 58:1291-1299.
240. Sharon G., Segala D., Ringob J.M., Hefetzc A., Zilber-Rosenbergd I., Rosenberga E. Commensal bacteria play a role in mating preference of Drosophila melanogaster. Prod Natl Acad Sci USA 2010, 107:20051-20056.
241. Shida K., Nanno M. Probiotics and immunology: separating the wheat from the chaff. Trends Immunol 2008, 29:565-573.
242. Shin S.C., Kim H., You H., Kim B., Kim A.C., Lee K., et al. Drosophila microbiome modulates host developmental and metabolic homeostasis via insulin signaling. Science 2011, 334:670-674.
243. Shklovskaya E., O'Sullivan B.J., Ng L.G., Roediger B., Thomas R., Weninger W., et al. Langerhans cells are precommitted to immune tolerance induction. Proc Natl Acad Sci U S A 2011, 108:18049-18054.
244. Smillie C.S., Smith M.B., Friedman J., Cordero O.X., David L.A., Alm E.J. Ecology drives a global network of gene exchange connecting the human microbiome. Nature 2011, 480:241-244.
245. Smith P.M., Garrett W.S. The gut microbiota and mucosal T cells. Front Microbiol 2011, 2:111.
246. Smith K.S., Mccoy K.D., Macpherson A.J. Use of axenic animals in studying the adaptation of mammals to their commensal intestinal micro-biota. Semin Immunol 2007, 19:59-69.
247. Sokol H., Seksik P., Rigottier-Gois L., Lay C., Lepage P., Podglajen I., et al. Specificities of the fecal microbiota in inflammatory bowel disease. Inflamm Bowel Dis 2006, 12:106-111.
248. Sokol H., Pigneur B., Watterlot L., Lakhdari O., Bermudez-Humaran L.G., Gratadoux J., et al. Faecalibacterium prausnitzii is an anti-inflammatory commensal bacterium identified by gut microbiota analysis of Crohn's disease patients. Proc Natl Acad Sci U S A 2008, 105:16731-16736.
249. Sokol H., Seksik P., Furet J.P., Firmesse O., Nion-Larmurier I., Beaugerie L., et al. Low counts of Faecalibacterium prausnitzii in colitis microbiota. Inflamm Bowel Dis 2009, 15:1183-1189.
250. Song X., Zhu S., Shi P., Liu Y., Shi Y., Levin S.D., et al. IL-17RE is the functional receptor for IL-17C and mediates mucosal immunity to infection with intestinal pathogens. Nat Immunol 2011, 12:1151-1158.
251. Sonnenburg J.L., Xu J., Leip D.D., Chen C., Westover B.P., Weatherford J., et al. Glycan foraging in vivo by an intestine-adapted bacterial symbiont. Science 2005, 307:1955-1959.
252. Sonnenburg E.D., Zheng H., Joglekar P., Higginbottom S.K., Firbank S.J., Bolm D.N., et al. Specificity of polysaccharide use in intestinal Bacteroides species determines diet-induced microbiota alterarions. Cell 2010, 141:1241-1252.
253. Sonoyama K., Ogasawara T., Goto H., Yoshida T., Takemura N., Fujiwara R., et al. Comparison of gut microbiota and allergic reactions in BALB/c mice fed different cultivars of rice. Br J Nutr 2010, 103:218-226.
254. Spor A., Koren O., Ley R. Unravelling the effects of the environment and host genotype on the gut microbiobe. Nat Rev Microbiol 2011, 9:279-290.
255. Stolfi C., Rizzo A., Franzè E., Rotondi A., Fantini M.C., Sarra M., et al. Involvement of interleukin-21 in the regulation of colitis-associated colon cancer. J Exp Med 2011, 208:2279-2290.
256. Strozzi G.P., Mogna L. Quantification of folic acid in human feces after administration of Bifidobacterium probiotic strains. J Clin Gastroenterol 2008, 42(Suppl. 3):S179-S184.
257. Suzuki K., Meek B., Doi Y., Muramatsu M., Chiba T., Honjo T., et al. Aberrant expansion of segmented filamentous bacteria in IgA-deficient gut. Proc Natl Acad Sci U S A 2004, 101:1981-1986.
258. Swidsinski A., Weber J., Loening-Baucke V., Hale L.P., Lochs H. Spatial organization and composition of the mucosal flora in patients with inflammatory bowel disease. J Clin Microbiol 2005, 43:3380-3389.
259. Tang Y., Chen Y., Jiang H., Robbins G.T., Nie D. G-protein-coupled receptor for short-chain fatty acids suppresses colon cancer. Int J Cancer 2011, 128:847-856.
260. Tanoue T., Nishitani Y., Kanazawa K., Hashimoto T., Mizuno M. In vitro model to estimate gut inflammation using co-cultured Caco-2 and RAW264.7 cells. Biochem Biophys Res Commun 2008, 374:565-569.
261. Tasse L., Bercovici J., Pizzut-Serin S., Robe P., Tap J., Klopp C., et al. Functional metagenomics to mine the human gut microbiome for dietary fiber catabolic enzymes. Genome Res 2010, 20:1605-1612.
262. Thomas F., Hehemann J.H., Rebuffet E., Czjzek M., Michel G. Environmental and gut bacteroidetes: the food connection. Front Microbiol 2011, 2:93.
263. Tien M.T., Girardin S.E., Regnault B., Le Bourhis L., Dillies M.A., Coppée J.Y., et al. Anti-inflammatory effect of Lactobacillus casei on Shigella-infected human intestinal epithelial cells. J Immunol 2006, 176:1228-1237.
264. Tilg H., Kaser A. Gut microbiome, obesity, and metabolic dysfunction. J Clin Invest 2011, 121:2126-2132.
265. Turnbaugh P.J., Ley R.E., Mahowald M.A., Magrini V., Mardis E.R., Gordon J.I. An obesity-associated gut microbiome with increased capacity for energy harvest. Nature 2006, 444:1027-1031.
266. Turnbaugh P.J., Hamady M., Yatsunenko T., Cantarel B.L., Duncan A., Ley R.E., et al. A core gut microbiome in obese and lean twins. Nature 2009, 457:480-484.
267. Turnbaugh P.J., Ridaura V.K., Faith J.J., Rey F.E., Knight R., Gordon J.I. The effect of diet on the human gut microbiome: a metagenomic analysis in humanized gnotobiotic mice. Sci Transl Med 2009, 1:6-14.
268. Turnbaugh P.J., Quince C., Faith J.J., McHardy A.C., Yatsunenko T., Niazi F., et al. Organismal, genetic, and transcriptional variation in the deeply sequenced gut microbiomes of identical twins. Proc Natl Acad Sci U S A 2010, 107:7503-7508.
269. Turroni F., Bottacini F., Foroni E., Mulder I., Kim J.H., Zomer A., et al. Genome analysis of Bifidobacterium bifidum PRL2010 reveals metabolic pathways for host-derived glycan foraging. Proc Natl Acad Sci U S A 2010, 107:19514-19519.
270. Turroni F., Milani C., van Sinderen D., Ventura M. Genetic strategies for mucin metabolism in Bifidobacterium bifidum PRL2010: an example of possible human-microbe co-evolution. Gut Microbes 2011, 2:183-189.
271. Tziannabos A.O. Polysaccharide immunomodulators as therapeutic agents: structural aspects and biological function. Clin Microbiol Rev 2000, 13:523-533.
272. Vaahtovuo J., Munukka E., Korkeamaki M., Luukkainen R., Toivanen P. Fecal microbiota in early rheumatoid arthritis. J Rheumatol 2008, 35:1500-1505.
273. Vaishnava S., Behrendt C.L., Ismail A.S., Eckmann L., Hooper L.V. Paneth cells directly sense gut commensals and maintain homeostasis at the intestinal host-microbial interface. Proc Natl Acad Sci U S A 2008, 105:20858-20863.
274. Vaishnava S., Yamamoto M., Severson K.M., Ruhn K.A., Yu X., Koren O., et al. The antibacterial lectin RegIIIγ promotes the spatial segregation of microbiota and host in the intestine. Science 2011, 334:255-258.
275. van Passel M.W., Kant R., Zoetendal E.G., Plugge C.M., Derrien M., Malfatti S.A., et al. The genome of Akkermansia muciniphila, a dedicated intestinal mucin degrader, and its use in exploring intestinal metagenomes. PLoS One 2011, 6:e16876.
276. Vavricka S.R., Musch M.W., Chang J.E., Nakagawa Y., Phanvijhitsiri K., Waypa T.S., et al. hPepT1 transports muramyl dipeptide, activating NF-kB and stimulating IL-8 secretion in human colonic Caco2/bbe cells. Gastroenterology 2004, 127:1401-1409.
277. Verberkmoes N.C., Russell A.L., Shah M., Godzik A., Rosenquist M., Halfvarson J., et al. Shotgun metaproteomics of the human distal gut microbiota. ISME J 2009, 3:179-189.
278. Vetvicka V., Dvorak B., Vetvickova J., Richter J., Krizan J., Sima P., et al. Orally administered marine (1→3)-beta-D-glucan Phycarine stimulates both humoral and cellular immunity. Int J Biol Macromol 2007, 40:291-298.
279. Vijay-Kumar M., Aitken J.D., Carvalho F.A., Cullender T.C., Mwangi S., Srinivasan S., et al. Metabolic syndrome and altered gut microbiota in mice lacking Toll-like receptor-5. Science 2010, 327:228-231.
280. Volman J.J., Helper J.P., Baars J.J., Van Griensven L.J., Sonnenberg A.S., Mensink R.P., et al. Effects of mushroom-derived beta-glucan-rich polysaccharide extracts on nitric oxide production by bone marrow-derived macrophages and nuclear factor-kappaB transactivation in Caco-2 reporter cells: can effects be explained by structure?. Mol Nutr Food Res 2010, 54:268-276.
281. Volman J.J., Mensink R.P., Ramaker J.D., de Winther M.P., Carlsen H., Blomhoff R., et al. Dietary (1→3), (1→4)-beta-D-glucans from oat activate nuclear factor-kappaB in intestinal leukocytes and enterocytes from mice. Nutr Res 2010, 30:40-48.
282. Vonarbourg C., Mortha A., Bui V.L., Hernandez P.P., Kiss E.A., Hoyler T., et al. Regulated expression of nuclear receptor RORγt confers distinct functional fates to NK cell receptor-expressing RORγt(+) innate lymphocytes. Immunity 2010, 33:736-751.
283. Vrieze A., Holleman F., Serlie M.J., Ackermans M.T., Dallinga-Thie G.M., Groen A.K., et al. Metabolic effects of transplanting gut microbiota from lean donors to subjects with metabolic syndrome. The European Association for the Study of Diabetes Meeting 2010.
284. Walker A.W., Ince J., Duncan S.H., Webster L.M., Holtrop G., Ze X., et al. Dominant and diet-responsive groups of bacteria within the human colonic microbiota. ISME J 2011, 5:220-230.
285. Walton K.L., He J., Kelsall B.L., Sartor R.B., Fisher N.C. Dendritic cells in germ-free and specific pathogen-free mice have similar phenotypes and in vitro antigen presenting function. Immunol Lett 2006, 102:16e24.
286. Wang H., Weening D., Jonkers E., Boer T., Stellaard F., Small A.C., et al. A curve fitting approach to estimate the extent of fermentation of indigestible carbohydrates. Eur J Clin Invest 2008, 38:863-868.
287. Wasser S.P. Current finding, future trends and unsolved problems in studies of medical mushroom. Appl Microbiol Biotechnol 2011, 89:1323-1332.
288. Weirdt R.D., Possemiers S., Vermeulen G., Moerdijk-Poortvliet T.C., Boschker H.T., Verstraete W., et al. Human faecal microbiota display variable patterns of glycerol metabolism. FEMS Microbiol Ecol 2010, 74:601-611.
289. Wells J.M., Rossi O., Meijerink M., van Baarlen P. Epithelial crosstalk at the microbiota-mucosal interface. Proc Natl Acad Sci U S A 2011, 108(Suppl. 1):4607-4614.
290. Wen L., Ley R.E., Volchkov P.Y., Stranges P.B., Avanesyan L., Stonebraker A.C., et al. Innate immunity and intestinal microbiota in the development of Type 1 diabetes. Nature 2008, 455:1109-1113.
291. Willing B.P., Van Kessel A.G. Enterocyte proliferation and apoptosis in the caudal small intestine is influenced by the composition of colonizing commensal bacteria in the neonatal gnotobiotic pig. J Anim Sci 2007, 85:3256-3266.
292. Wlodarska M., Willing B., Keeney K.M., Menendez A., Bergstrom K.S., Gill N., et al. Antibiotic treatment alters the colonic mucus layer and predisposes the host to exacerbated Citrobacter rodentium-induced colitis. Infect Immun 2011, 79:1536-1545.
293. Wolk K., Witte E., Witte K., Warszawska K., Sabat R. Biology of interleukin-22. Semin Immunopathol 2010, 32:17-31.
294. Wong J.M., de Souza R., Kendall C.W., Emam A., Jenkins D.J. Colonic health; fermentation and short chain fatty acids. J Clin Gastroenterol 2006, 40:235-243.
295. Woodmansey E.J. Intestinal bacteria and ageing. J Appl Microbiol 2007, 102:1178-1186.
296. Wu H.J., Ivanov I.I., Darce J., Hattori K., Shima T., Umesaki Y., et al. Gut-residing segmented filamentous bacteria drive autoimmune arthritis via T helper 17 cells. Immunity 2010, 32:815-827.
297. Wu G.D., Chen J., Hoffmann C., Bittinger K., Chen Y., Keilbaugh S.A., et al. Linking long-term dietary patterns with gut microbial enterotypes. Science 2011, 334:105-108.
298. Xiong Y., Miyamoto N., Shibata K., Valasek M.A., Motoike T., Kedzierski R.M., et al. Short-chain fatty acids stimulate leptin production in adipocytes through the G protein-coupled receptor GPR41. Proc Natl Acad Sci U S A 2004, 101:1045-1050.
299. Xu X.F., Yan H.D., Tang J., Chen J., Zhang X.W. Polysaccharides in Lentinus edodes: isolation, structure, immuno-modulating activity and future prospective. Crit Rev Food Sci Nutr 2012, 10.1080/10408398.2011.587616.
300. Zaki M.H., Boyd K.L., Vogel P., Kastan M.B., Lamkanfi M., Kanneganti T.D. The NLRP3 inflammasome protects against loss of epithelial integrity and mortality during experimental colitis. Immunity 2010, 32:379-391.
301. Zaki M.H., Vogel P., Body-Malapel M., Lamkanfi M.L., Kanneganti T.D. IL-18 production downstream of the Nlrp3 inflammasome confers protection against colorectal tumor formation. J Immunol 2010, 185:4912-4920.
302. Zaph C., Troy A.E., Taylor B.C., Berman-Booty L.D., Guild K.J., Du Y., et al. Epithelial-cell-intrinsic IKK-beta expression regulates intestinal immune homeostasis. Nature 2007, 446:552-556.
303. Zhang X.W., Yap Y., Wei D., Chen G., Chen F. Novel omics technologies in nutrition research. Biotechnol Adv 2008, 26:169-176.
304. Zhang H., DiBaise J.K., Zuccolo A., Kudrna D., Braidotti D.Y., Parameswaran P., et al. Human gut microbiota in obesity and after gastric bypass. Proc Natl Acad Sci U S A 2009, 106:2365-2370.
305. Zhu L., Wu Q., Dai J., Zhang S., Wei F. Evidence of cellulose metabolism by the giant panda gut microbiome. Proc Natl Acad Sci U S A 2011, 108:17714-17719.
306. Zhu Y., Michelle L.T., Jobin C., Young H.A. Gut microbiota and probiotics in colon tumorigenesis. Cancer Lett 2011, 309:119-127.
307. Zwielehner J., Liszt K., Handschur M., Lassl C., Lapin A., Haslberger A.G. Combined PCR-DGGE fingerprinting and quantitative-PCR indicates shifts in fecal population sizes and diversity of Bacteroides, bifidobacteria and Clostridium cluster IV in institutionalized elderly. Exp Gerontol 2009, 44:440-446.